Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Memorial Sloan Kettering Cancer Center
Jazz Pharmaceuticals
Daiichi Sankyo
HealthPartners Institute
Stanford University
Mayo Clinic
University of Washington
City of Hope Medical Center
Bayer
Astellas Pharma Inc
Tempus AI
Brown University
Pfizer
National Cancer Institute (NCI)
British Columbia Cancer Agency
Washington University School of Medicine
University of California, Irvine
Tongji Hospital
Elevation Oncology
Optimal Health Research
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zhejiang Provincial People's Hospital
Exelixis
National Institutes of Health Clinical Center (CC)
Sun Yat-sen University
Erasmus Medical Center
Universitair Ziekenhuis Brussel
Fondazione per la Medicina Personalizzata
pharmaand GmbH
OncoNano Medicine, Inc.
Jules Bordet Institute
Second Affiliated Hospital of Soochow University
Ambrx, Inc.
Bayer
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Advanced Accelerator Applications
DEKK-TEC, Inc.
MetiMedi Pharmaceuticals
Sun Yat-sen University
Tetra Bio-Pharma
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)